THOMAS, AJIROGHENE
 Distribuzione geografica
Continente #
NA - Nord America 3.777
EU - Europa 2.023
AS - Asia 1.112
SA - Sud America 164
Continente sconosciuto - Info sul continente non disponibili 114
AF - Africa 43
OC - Oceania 5
Totale 7.238
Nazione #
US - Stati Uniti d'America 3.665
PL - Polonia 558
CN - Cina 462
RU - Federazione Russa 407
SG - Singapore 319
IT - Italia 304
DE - Germania 172
BR - Brasile 132
FR - Francia 119
GB - Regno Unito 119
UA - Ucraina 91
CA - Canada 89
HK - Hong Kong 89
VN - Vietnam 87
SE - Svezia 83
FI - Finlandia 82
KR - Corea 40
ZA - Sudafrica 35
TR - Turchia 33
IE - Irlanda 20
IN - India 19
BE - Belgio 17
AR - Argentina 15
NL - Olanda 14
JP - Giappone 13
MX - Messico 13
EU - Europa 9
ES - Italia 8
AT - Austria 6
IQ - Iraq 6
CZ - Repubblica Ceca 5
EC - Ecuador 5
JO - Giordania 5
AE - Emirati Arabi Uniti 4
CO - Colombia 4
GR - Grecia 4
ID - Indonesia 4
PK - Pakistan 4
SA - Arabia Saudita 4
AU - Australia 3
AZ - Azerbaigian 3
BD - Bangladesh 3
DZ - Algeria 3
TT - Trinidad e Tobago 3
BY - Bielorussia 2
CL - Cile 2
CR - Costa Rica 2
DK - Danimarca 2
GE - Georgia 2
IR - Iran 2
KE - Kenya 2
LT - Lituania 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PY - Paraguay 2
RO - Romania 2
RS - Serbia 2
TH - Thailandia 2
UZ - Uzbekistan 2
VE - Venezuela 2
BB - Barbados 1
BG - Bulgaria 1
CM - Camerun 1
CY - Cipro 1
DM - Dominica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
MA - Marocco 1
OM - Oman 1
PE - Perù 1
PR - Porto Rico 1
SI - Slovenia 1
SY - Repubblica araba siriana 1
UY - Uruguay 1
Totale 7.133
Città #
Warsaw 450
Fairfield 349
Woodbridge 313
Ashburn 289
Dallas 262
Jacksonville 224
Houston 176
Chandler 170
Singapore 170
Ann Arbor 151
Cambridge 149
Seattle 145
San Jose 143
Wilmington 139
Kraków 102
Council Bluffs 98
Hong Kong 87
Boardman 86
Beijing 82
Nanjing 76
Camerino 69
Toronto 56
Los Angeles 52
Helsinki 44
New York 42
The Dalles 42
Seoul 34
Ho Chi Minh City 31
Santa Clara 31
Johannesburg 30
San Mateo 28
Columbus 27
Lawrence 27
Moscow 27
Princeton 27
Tongling 27
Istanbul 26
Shanghai 25
Dearborn 23
Lauterbourg 22
Munich 22
Ogden 21
Dublin 20
Düsseldorf 20
Lachine 20
London 20
Nanchang 20
Centro 19
São Paulo 18
Brussels 17
Buffalo 15
Chicago 15
Hanoi 15
Kunming 15
Shenyang 14
Tianjin 14
San Diego 13
Milan 12
Phoenix 12
Guangzhou 11
Orem 10
Tokyo 10
Hangzhou 9
Hefei 9
Poplar 9
Turku 9
Changsha 8
Frankfurt am Main 8
Hebei 8
Meppel 8
Philadelphia 8
San Francisco 8
Stockholm 8
Brooklyn 7
Jiaxing 7
Manchester 7
Ningbo 7
Montreal 6
Redwood City 6
Scuola 6
Tappahannock 6
Verona 6
Zhengzhou 6
Biên Hòa 5
Boston 5
Denver 5
Falls Church 5
Mexico City 5
New Bedfont 5
Nürnberg 5
Perugia 5
Rome 5
Salt Lake City 5
Atlanta 4
Belo Horizonte 4
Cagliari 4
Chennai 4
Dong Ket 4
North Bergen 4
Norwalk 4
Totale 4.938
Nome #
1,2,4-Triazolo[1,5-a]quinoxaline derivatives and their simplified analogues as adenosine A3 receptor antagonists. Synthesis, structure–affinity relationships and molecular modeling studies 652
The Length and Flexibility of the 2-Substituent of 9-Ethyladenine Derivatives Modulate Affinity and Selectivity for the Human A2A Adenosine Receptor 412
Overview on Radiolabel-Free in Vitro Assays for GPCRs 407
The G Protein-Coupled Receptor GPR17: Overview and Update 375
2′,3′-O-Substituted ATP derivatives as potent antagonists of purinergic P2X3 receptors and potential analgesic agents 368
A Novel Class of Dopamine D4 Receptor Ligands Bearing an Imidazoline Nucleus 303
8-(2-Furyl)adenine derivatives as A2A adenosine receptor ligands 297
Neuropeptide S Receptor: recent updates on non-peptide antagonist discovery 281
33rd camerino-Cyprus Symposium - Receptor Chemistry: Reality and Vision 273
Medicinal Chemistry of P2X Receptors: Agonists and Orthosteric Antagonists 271
Simulation and Comparative Analysis of Different Binding Modes of Non-nucleoside Agonists at the A2A Adenosine Receptor 270
Antiproliferative Evaluation of Isofuranodiene on Breast and Prostate Cancer Cell Lines 250
New substituted 9-propyladenine derivatives as A2Aadenosine receptor antagonists 241
Purinergic P2X receptors: Structural models and analysis of ligand-target interaction 240
Innovative functional cAMP assay for studying G protein-coupled receptors: application to the pharmacological characterization of GPR17 235
Exploring the 7-oxo-thiazolo[5,4-d]pyrimidine core for the design of new human adenosine A3 receptor antagonists. Synthesis, molecular modeling studies and pharmacological evaluation 226
33rd Camerino-Cyprus Symposium - Receptor Chemistry: Reality and Vision 225
Molecular modeling study on potent and selective adenosine A3 receptor agonists. 224
Evidence for the existence of a specific G protein-coupled receptor activated by guanosine 222
Imidazo[1,2-a]pyrazin-8-amine core for the design of new adenosine receptor antagonists: Structural exploration to target the A3 and A2A subtypes 214
Different efficacy of adenosine and NECA derivatives at the human A3 adenosine receptor: Insight into the receptor activation switch 213
Innovative functional cAMP assay: application to the pharmacological characterization of GPR17 201
Simulation and comparative analysis of binding modes of nucleoside and non-nucleoside agonists at the A2B adenosine receptor 201
Evaluation of adenine as scaffold for the development of novel P2X3 receptor antagonists 197
Functional cAMP assay optimization at CHO cells expressing A2A adenosine receptors and stably transfected with firefly luciferase biosensor 186
Purinergic P2X receptors: Structural models and analysis of receptor-ligand interaction 169
Synthesis of ligands for receptors involved in neurodegeneration 85
Totale 7.238
Categoria #
all - tutte 25.334
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.334


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022313 0 77 12 13 24 22 13 30 27 37 26 32
2022/2023410 52 37 11 70 33 54 7 25 59 18 28 16
2023/2024292 38 14 26 10 16 28 15 23 30 10 5 77
2024/20251.052 29 25 69 60 26 75 141 288 76 53 76 134
2025/20261.594 89 100 336 197 205 138 189 72 62 107 62 37
2026/2027123 85 38 0 0 0 0 0 0 0 0 0 0
Totale 7.238